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gene, mostly heterozygous missense mutations, 
typically glycine substitutions in the Gly ‑X‑Y re‑
peat, or splice ‑site variants affecting the triple 
helical sequence leading to altered type III colla‑
gen synthesis and assembly.2,3 As a consequence 
of a molecular defect in the COL3A1 gene, resis‑
tance to mechanical stress of the arteries, bow‑
el, and uterus is decreased.4 Women with vEDS 
have an increased risk of obstetric complications 
including uterine rupture and dissection of ma‑
jor arteries and veins.5
To our knowledge, we report the first 2 Polish 
patients with vEDS in whom new causal muta‑
tions have been detected.
Case 1 A 33‑year ‑old woman (height, 158 cm; 
weight, 48 kg) was referred to John Paul II Hos‑
pital, Kraków, Poland, for genetic workup. At the 
age of 2, she underwent Achilles tenotomy due 
to clubfoot, and at the age of 29, she underwent 
stent implantation for the spontaneous right 
common iliac artery aneurysm and dissection. 
At the age of 32, she experienced spontaneous 
sigmoid colon perforation and underwent colos‑
tomy with partial colectomy. She was pregnant 
twice and gave birth by uneventful vaginal deliv‑
ery. Currently, computed tomography angiogra‑
phy showed that the ascending and descending 
aortic segments were not dilated; the maximum 
diameter of the abdominal aorta at the level of 
the bifurcation was 20 mm, along with dilation 
Introduction The Ehlers–Danlos syndrome 
(EDS) is a genetically and clinically heteroge‑
neous disorder involving joint hypermobili‑
ty, skin hyperextensibility, and tissue fragili‑
ty.1 According to the 2017 international classi‑
fication,2 EDS is divided into 13 types. Vascular 
EDS (vEDS) is the most severe form inherited 
in an autosomal dominant pattern and char‑
acterized by an increased risk of sudden death 
due to the rupture of large arteries, gastroin‑
testinal perforation, or uterine rupture during 
pregnancy (for criteria, see Supplementary ma‑
terial, Table S1). Additional symptoms defining 
this syndrome are thin translucent skin with 
prominent subcutaneous vessels, easy bruising, 
small joint hypermobility, early ‑onset varicose 
veins, and tendon or muscle rupture.1 The mini‑
mal criteria suggestive of vEDS (ie, family histo‑
ry of the disorder, arterial rupture or dissection 
in individuals younger than 40 years of age, un‑
explained sigmoid colon rupture, or spontane‑
ous pneumothorax in the presence of other fea‑
tures consistent with vEDS) should all lead to 
diagnostic workup to verify if the clinical diag‑
nosis could be confirmed by genetic testing. Mo‑
lecular testing for vEDS should also be consid‑
ered in the presence of a combination of the oth‑
er “minor” clinical features listed in Supplemen‑
tary material, Table S1.2
Vascular EDS is usually caused by mutations 
in the collagen type III alpha I chain (COL3A1) 
Correspondence to: 
Ewa Wypasek, PhD, 















S H O R T  C O M M U N I C A T I O N
Vascular Ehlers–Danlos syndrome 
in 2 Polish patients: identification 
of 2 novel COL3A1 gene mutations
Małgorzata Konieczyńska1*, Ewa Wypasek2,3*, Marek Karpiński1, 








S H O R T  C O M M U N I C A T I O N  Vascular Ehlers ‑Danlos syndrome in Polish patients 1071
The patient’s father (at the age of 39) and 
brother (at the age of 18) experienced a fatal 
thoracic aorta dissection. Her paternal grand‑
mother underwent a successful operation for 
the ascending aortic aneurysm at the age of 66, 
while her 2 sisters, 1 brother, and 2 children re‑
main asymptomatic. The relatives were not ge‑
netically tested.
of the right common iliac artery to 16 mm and 
the left common iliac artery to 17 mm. There were 
no abnormalities in other vessels. Transthorac‑
ic echocardiography showed no abnormalities.
On physical examination, joint hypermobility 
(9‑point Beighton scale, 6 points) and increased 
skin elasticity were observed. The skin was thin 
and shiny with signs of bruising and atrophic scars.
Figure 1  Case 2. Joint hypermobility in the fingers (A) and thumb (B), elbow bending (C), as well as translucent skin with 
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complications.9,10 In these cases, lifestyle changes 
can be recommended to minimize the risk of in‑
juries in the future, and regular control visits and 
clinical surveillance are extremely important. Typ‑
ical joint and skin manifestations should draw at‑
tention of a consulting cardiologist to vEDS.
Regarding reproductive history, the first pa‑
tient gave birth to 2 children. However, accord‑
ing to the 2018 European Society of Cardiolo‑
gy guidelines, pregnancy in women with vEDS 
is not recommended (class IIIC) due to high risk 
of serious vascular complications.11 Murray et al12 
reported that life ‑threatening complications 
occurred in 14.5% of deliveries in women with 
vEDS, including arterial dissection / rupture 
(9.2%), uterine rupture (2.6%), surgical com‑
plications (2.6%), and finally, the pregnancy‑
‑related death rate of 5.3%. It is unclear wheth‑
er an elective cesarean section decreases mor‑
tality among such women.5
Our report clearly indicates that molecular 
analysis should be conducted in young patients 
with unexplained bowel or arterial rupture and 
also in patients with a family history of similar 
events. The 2 familial cases we presented here 
also illustrate the clinical variability of the dis‑
order, which means that carriers of the same 
mutation may present variable clinical presen‑
tations.13 Importantly, genetically confirmed 
vEDS may influence pregnancy and reproduc‑
tive counseling. Pregnant women with vEDS 
should be considered to be at high risk of com‑
plications and they need to be referred to spe‑
cialized centers. Our report also draws atten‑
tion to the importance of searching for genet‑
ic causes of rare diseases in Poland, including 
thrombophilia.14,15 Molecular genetic analysis 
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Case 2 A 26‑year ‑old woman (height, 167 cm; 
weight, 62 kg) complained of hypermobility of 
the small joints and easy bruising. At the age 
of 13, she broke her right ankle, and at the 
age  of  19, she twisted the  knee joint, and 
a year later she underwent a reconstruction 
of anterior cruciate ligament of the right knee. 
A recurrent ligament rupture occurred at the age 
of 21, and the reoperation was performed a year 
later. For 6 years, she had had recurrent luxation 
in the arm joint and the right wrist. She showed 
no cardiac symptoms and her transesophageal 
echocardiography showed only mild tricuspid in‑
sufficiency. She had never been pregnant.
On examination, joint hypermobility (9‑point 
Beighton scale, 7 points) and a thin, translucent 
skin with prominent subcutaneous vessels were 
noted (FIGURE 1).
The patient’s father died of an aortic dissec‑
tion at the age of 45. He also suffered from joint 
hypermobility. Her grandfather died of an aor‑
tic aneurysm rupture. The relatives were not ge‑
netically tested.
Genetic testing After obtaining written in‑
formed consent, the molecular analysis was per‑
formed on genomic DNA by polymerase chain 
reaction amplification of all coding exons and 
the  flanking intron regions. The  amplicons 
were analyzed by the sequencing ‑by ‑synthesis 
(SBS) technology (MiSeq Personal Sequencer, 
Illumina, San Diego, California, United States). 
The gene panel including FBN1, TGFBR1, TGF-
BR2, TGFB2, SMAD2, SMAD3, ACTA2, COL3A1, 
MYH11, TGFB3, and SKI genes was selected based 
on the clinical signs and a positive family histo‑
ry. The presence of the variants was confirmed 
by Sanger sequencing. The sensitivity of SBS se‑
quencing is more than 99.9%.
We identified 2 novel COL3A1 mutations, 
c.1348‑2A>G and c.1455+1G>T in cases 1 and 2, 
respectively. Both mutations disrupt the nor‑
mal splice sites, thereby interfering with nor‑
mal splicing. In our patient (case 1), a history 
of colon perforation and the iliac artery aneu‑
rysm and dissection can be considered as typ‑
ical. In contrast to older patients with aneu‑
rysms,6 at a younger age, genetic syndromes 
associated with aortic aneurysmal disease are 
relatively common.7 In vEDS, spontaneous ar‑
terial rupture is most prevalent in the third and 
fourth decades of life and often involves thorac‑
ic or abdominal vessels as well as the descend‑
ing and abdominal aorta.5,8 There is no specific 
treatment for vEDS; however, an early diagnosis 
can help monitor disease progression. Patients 
should be offered genetic counselling. The risk of 
an affected parent passing on the mutation to 
their child can be as high as 50%.5
In our second case, a recurrent ligament rup‑
ture was observed. Mutations in the COL3A1 
gene have been reported to lead to this type of 
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